Glucose Health Inc. (GLUC)

[DukeOBass]

They had previously told investors they need $300,000 by the end of 2014 to continue and that the money might have to come from them (you all). I wonder what that amount is up to now?

They will have to pay the pharmacist to mix the compound, for packaging, for marketing and for physical shelf space (unless they strictly sell online and that also involves some type of cost). The previous unknown product did not do very well on Amazon.

The share price continues to drop and may have to be propped up by yet another reverse split. Nothing states that yet, but there are always disappointments (I mean surprises) here.

Glucose Health formerly sought its operating capital by going public under the business name Bio-Solutions Corp. Late last year the company sought a name change to Glucose Health and reorganized. The company shares now trade over-the-counter under the ticker symbol GLUC with a share price of 7 cents. Fleming owns a 50% stake since taking over as CEO.

The concerns noted by the company in its most recent filing with the Securities and Exchange Commission (Sept. 2014) was its lack of profits thus far under the former management. All publicly traded companies are required to post any potential risks to investors. With that, the company notes that its officers and directors going forward may need to contribute added capital to sustain operations if product sales should stall.